12:00 AM
 | 
Sep 18, 2000
 |  BC Week In Review  |  Company News  |  Deals

Akkadix, Pangene deal

Akkadix received an exclusive license to Pangene's enhanced Homologous Recombination (eHR) technology for DNA modification and rearrangement in...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >